| Dr Fred Nmn Fisch, OD | |
|
1950 S Country Club Dr, Mesa, AZ 85210-6008 | |
| (480) 834-6367 | |
| Not Available |
| Full Name | Dr Fred Nmn Fisch |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 44 Years |
| Location | 1950 S Country Club Dr, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003814419 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 618 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prime Eye Care Pc | 4789678301 | 8 |
News Archive
MiddleBrook Pharmaceuticals, Inc. today announced its financial and operational results for the quarter ended Sept. 30, 2009.
The American Pharmacists Association has selected Elsevier, a world-leading provider of scientific, technical and medical information products and services, as its exclusive publisher, promoter and distributor of APhA publications Pharmacy Today, Journal of the American Pharmacists Association, and Journal of Pharmaceutical Sciences.
What happens in intestinal epithelial cells during a chronic illness? Basic research conducted at the Chair of Nutrition and Immunology at the Technical University of Munich addressed this question by generating a new model system.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 6 days ago
| Provider Name | Prime Eye Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447226295 PECOS PAC ID: 4789678301 Enrollment ID: O20040414001072 |
News Archive
MiddleBrook Pharmaceuticals, Inc. today announced its financial and operational results for the quarter ended Sept. 30, 2009.
The American Pharmacists Association has selected Elsevier, a world-leading provider of scientific, technical and medical information products and services, as its exclusive publisher, promoter and distributor of APhA publications Pharmacy Today, Journal of the American Pharmacists Association, and Journal of Pharmaceutical Sciences.
What happens in intestinal epithelial cells during a chronic illness? Basic research conducted at the Chair of Nutrition and Immunology at the Technical University of Munich addressed this question by generating a new model system.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fred Nmn Fisch, OD 9743 E Palm Ridge Dr, Scottsdale, AZ 85260-3879 Ph: (480) 661-6158 | Dr Fred Nmn Fisch, OD 1950 S Country Club Dr, Mesa, AZ 85210-6008 Ph: (480) 834-6367 |
News Archive
MiddleBrook Pharmaceuticals, Inc. today announced its financial and operational results for the quarter ended Sept. 30, 2009.
The American Pharmacists Association has selected Elsevier, a world-leading provider of scientific, technical and medical information products and services, as its exclusive publisher, promoter and distributor of APhA publications Pharmacy Today, Journal of the American Pharmacists Association, and Journal of Pharmaceutical Sciences.
What happens in intestinal epithelial cells during a chronic illness? Basic research conducted at the Chair of Nutrition and Immunology at the Technical University of Munich addressed this question by generating a new model system.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 6 days ago
Alicia S Mccallen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1444 S Sossaman Rd, Mesa, AZ 85209 Phone: 480-333-6563 Fax: 480-333-6564 | |
Eyes On Site Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 2826 E Baseline Rd Ste 101, Mesa, AZ 85204 Phone: 480-626-8925 Fax: 480-704-4036 | |
Dr. Mark Peller, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1025 S Power Rd, Mesa, AZ 85206 Phone: 480-325-6277 Fax: 480-325-6278 | |
Dr. Dawn Michelle Martin, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3940 E University Dr, Ste 5, Mesa, AZ 85205 Phone: 480-832-0030 Fax: 480-924-7268 | |
Pearson Eyecare Group, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6555 E Southern Ave, #1508, Mesa, AZ 85206 Phone: 480-345-7520 | |
Jordan Bluth, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1055 S Stapley Dr, Mesa, AZ 85204 Phone: 480-833-9100 |